← USPTO Patent Grants

Deuterated 1,4-benzodiazepine-2,5-dione compound and use thereof

Grant US12577213B2 Kind: B2 Mar 17, 2026

Assignee

NINGBO COMBIREG PHARMACEUTICAL TECHNOLOGY CO., LTD.

Inventors

Gang Liu, Yao Ma, Wenjun Yu

Abstract

Disclosed are a deuterated 1,4-benzodiazepine-2,5-dione compound and the use thereof. Provided is a compound as represented by formula I or a pharmaceutically acceptable salt thereof. The disclosed 1,4-benzodiazepine-2,5-dione active compound maintains the activity of inhibiting tumor cells and tumor stem cells, and prolongs the degradation function of in-vitro human liver microsomes on the compound, such that the half-life period is significantly prolonged, which provides a safer and more reliable candidate for developing new anti-tumor drugs.

CPC Classifications

C07D 243/14 C07D 243/08 A61P 35/00 A61P 35/02 C07B 2200/05 C07B 59/002

Filing Date

2021-10-25

Application No.

18252039

Claims

16